CSIMarket Company Name, Ticker, Competitors, else..
 
Cyclo Therapeutics Inc   (NASDAQ: CYTH)
 

Cyclo Therapeutics Inc's Suppliers Performance

CYTH's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CYTH Costs vs Sales of Suppliers Growth Cyclo Therapeutics Inc's cost of sales deteriorated by 0 % year on year, sequentially cost of sales grew by 25.54 % in Q4.

• More on CYTH Suppliers



Cyclo Therapeutics Inc's cost of sales deteriorated by 0 % year on year, sequentially cost of sales grew by 25.54 % in Q4.

• More on CYTH Suppliers




Cyclo Therapeutics Inc's Comment on Supply Chain


The company generates most of its revenue from its legacy fine chemical business, which involves the sale of cyclodextrins and cyclodextrin complexes, the resale of cyclodextrins produced by other manufacturers, and licensed cyclodextrin products under the Trappsol® and Aquaplex® brands. The Trappsol® product line comprises over 261 cyclodextrin products, while the Aquaplex® line includes more than 116 products that combine cyclodextrins with active ingredients. Historically, nearly all Aquaplex® sales were made to Sigma-Aldrich Fine Chemical. The Trappsol® and Aquaplex® products are primarily used in the food and pharmaceutical industries. Major commercial manufacturers of natural and chemically modified cyclodextrins include Wacker Biosolutions, a division of Wacker.

Cyclo Therapeutics Inc's Comment on Supply Chain


The company generates most of its revenue from its legacy fine chemical business, which involves the sale of cyclodextrins and cyclodextrin complexes, the resale of cyclodextrins produced by other manufacturers, and licensed cyclodextrin products under the Trappsol® and Aquaplex® brands. The Trappsol® product line comprises over 261 cyclodextrin products, while the Aquaplex® line includes more than 116 products that combine cyclodextrins with active ingredients. Historically, nearly all Aquaplex® sales were made to Sigma-Aldrich Fine Chemical. The Trappsol® and Aquaplex® products are primarily used in the food and pharmaceutical industries. Major commercial manufacturers of natural and chemically modified cyclodextrins include Wacker Biosolutions, a division of Wacker.







CYTH's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cyclo Therapeutics Inc 20.70 0.87 -13.26 29
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cyclo Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cyclo Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.